David Spencer, MD, FCAP, discusses a new test for two blood cancers is the first whole-genome sequencing test for cancer to be approved for reimbursement. “If we want to look at additional genes or mutations, all we’d have to do is modify our data analysis slightly,” said Dr. Spencer.
For the full article click here: Medicare approves WashU Medicine’s whole-genome test for blood cancers